Ridzuan Mohd Syafiq Mohammad, Abdullah Azila, Ramly Rimatulhana, Mansor Nur Nazifah, Ramli Norazsida, Firdaus-Nawi Mohd
Department of Marine Science, Kulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.
National Fish Health Research Division, Fisheries Research Institute Batu Maung, Department of Fisheries Malaysia, 11960 Batu Maung, Penang, Malaysia.
Vet World. 2022 Feb;15(2):465-482. doi: 10.14202/vetworld.2022.465-482. Epub 2022 Feb 26.
Fish diseases have a significant negative influence on the Malaysian aquaculture industry. Since the 1980s, the sector has grown in size, which has resulted in a rise in the prevalence of infectious outbreaks affecting both freshwater and marine cultured fish species. Demand for commercially available fish vaccinations is predicted to increase as infectious disease outbreaks continue to occur. In Malaysia, aquaculture vaccine research and development (R&D) are still in its infancy, with most efforts concentrating on producing vaccines against bacterial infections, most notably streptococcosis, vibriosis, and motile Aeromonas septicemia. Despite several attempts, no homegrown vaccine has been effectively introduced into the manufacturing pipeline to date. At the moment, only three imported aquatic vaccines have received full permission, a far cry from the 314 and 60 vaccines licensed in the poultry and porcine industries, respectively. This review will describe recent findings regarding the development of aquaculture vaccines for certain fish species and diseases in Malaysia. In our opinion, R&D on fish vaccines is critical to the aquaculture industry's viability.
鱼类疾病对马来西亚水产养殖业产生了重大负面影响。自20世纪80年代以来，该行业规模不断扩大，导致影响淡水和海水养殖鱼类品种的传染病发病率上升。随着传染病疫情持续发生，预计对市售鱼类疫苗的需求将会增加。在马来西亚，水产养殖疫苗的研发仍处于起步阶段，大多数工作集中在生产针对细菌感染的疫苗，最显著的是链球菌病、弧菌病和运动性气单胞菌败血症。尽管进行了多次尝试，但迄今为止，尚未有国产疫苗有效地进入生产流程。目前，只有三种进口水产疫苗获得了完全许可，这与家禽和猪产业分别有314种和60种获许可的疫苗数量相差甚远。本综述将描述马来西亚近期有关某些鱼类品种和疾病的水产养殖疫苗开发的研究结果。我们认为，鱼类疫苗的研发对水产养殖业的生存能力至关重要。
